Abstract
Alterations of glycoconjugates are found to correlate with pathological states making 2 them new potential targets for therapeutic drugs and as biomarkers for diseases. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] The 3 human serum is highly glycosylated. [11] [12] [13] [14] In general, glycoconjugates are ubiquitous in 4 biological systems and are highly distributed on cell surfaces and in secreted proteins. As a 5 post-translational modification, glycosylation may be more responsive and sensitive to 6 changes in biological states. [2] [3] [4] [5] [6] [7] [8] [9] [10] 15, 16 However, the utility of glycoconjugates and the general 7 understanding of their functions are severely limited by the lack of rapid methods for 8 structural analysis. Indeed, the large variety of structures, the micro-heterogeneity, and the 9 unavailability of a biological template have conspired to severely limit our efforts to translate 10 the glycomic code. 17 
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Tandem MS spectra were used to further distinguish isomers and to add an additional GlcNac. Conversely, the other three isomers first lose sialic acid from the non-reducing end.
19
Isomer N5402c is the only one that does not have a α(2-3) sialic acid. The other isomers 20 contain at least one α(2-3) sialic acid suggesting that the α(2-3) linkage is more labile than 21 α(2-6). This observation is difficult to confirm due to the lack of standards, but it may be a 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 11 useful indicator of this specific structural feature. The CID of N5402d also appears to induce 1 a sialic acid migration producing a loss of an internal Gal residue. There is precedence for 2 monosaccharides migration in the tandem MS of native N-glycans. 38 The biantennary 3 di-sialylated compounds illustrate a limitation of this method. We were able to determine the 4 linkages on the more abundant mixed-linked species (N5402b) by tandem MS and enzymatic 5 digestion, however we could not isolate sufficient amounts of N5402d for similar analysis. Instead, the structure was assigned by deduction and elimination of the three more abundant 7 species.
8 Table S1 summarizes the comprehensive library containing over 170 distinct 9 compounds with over 50 complete structures and 100 partially elucidated structures. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 symbolic structures with annotated linkages, and relative abundances normalized to the total 1 N-glycan abundance are provided in Table S1 . were corrected by using the glycans in commercial serum as the standard oligosaccharide 6 mixture as described below.
7
The N-glycans released from serum are highly reproducible in the composition and 8 relative abundances. We have previously shown that there are generally small variations in 9 the abundances of the major components of N-glycans over hundreds of samples.
28,39

10
Indeed, serum N-glycans are so reproducible that they make a suitable standard mixture. In 11 this method, we use serum glycans to align chromatograms allowing this method to be 12 potentially transportable to other instruments and other laboratories.
13
Alignment of the chromatogram is performed systematically and stepwise using 14 groups of isomers. We first extract the chromatogram of a specific mass, for example that 
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The reproducibility of the technical replicates and the overall procedure was 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 examined by comparing retention times and abundances ( Figure S3 ). There is high 1 reproducibility in the total ion chromatogram as shown for both multiple injections (5x) and 2 multiple sample preparations (5x). The compound extraction chromatogram in Figure S4 3 shows the excellent overlap for five injections of the disialylated, biantennary structure.
4
Shown in Figure 4 is a comprehensively annotated chromatogram using the top 100 5 N-glycans. The numbers correspond to the entries with structures provided in Table S1 . The chromatography. 40 The structures correspond to N5402a, N5401a, N5511a, N5401b, N5410a, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 15 α-2-macroglobulin, transferrin and anti-trypsin. 33 
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As expected the CV in the individual structures is greater than those for the entire 2 glycan types. The CV for each structure is an indication of the biological diversity. The 3 structure with the highest CV corresponds to N3410a (31.5 %). For comparison the method 4 replicate yields a CV of 2.8% ( Figure S6 ). This compound N3410a is the most abundant 5 glycan in IgG and plays an important role in the effector function of the antibody. 32 The 6 second highest CV is N4410a, which is also derived from IgG. Conversely, the least 7 fluctuating N-glycan is the structure with N5400a with a CV of 8.7%. These results suggest 8 that the greatest variation in glycosylation is perhaps related to IgG glycosylation. corresponds to the di-sialylated bi-antennary species. We can now assign this structure as 17 being N5402a, the disialylated compound with both sialic acids linked via α(2,3).The second 18 most abundant structure (N5401a) accounts for about 6 %, the third to the seventh accounting 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 16 many more) structures. 
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